Details of Drug-Drug Interaction
| Drug General Information (ID: DDIN7A4HDC) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Alendronic acid | Drug Info | Parathyroid hormone | Drug Info | |||||
| Drug Type | Small molecule | Hormones | |||||||
| Therapeutic Class | Bone Density Conservation Agents | Hormone Modulators | |||||||
| Mechanism of Alendronic acid-Parathyroid hormone Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Alendronic acid | Parathyroid hormone | |||||||
| Mechanism | Reduce the therapeutic effects of parathyroid hormone | Parathyroid hormone | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacodynamics | ||||||||
| Factor Description | Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Concomitant use of parathyroid hormone with alendronate is not recommended. | ||||||||
| References | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Product Information. Fosamax (alendronate). Merck & Co, Inc, West Point, PA. | ||||||||||||||||||
| 2 | Product Information. Natpara (parathyroid hormone). NPS Pharmaceuticals, Bedminster, NJ. | ||||||||||||||||||
